Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Preventing another ischemic stroke with a smart bracelet and app

Official title: Prevention of Ischemic Stroke Recurrence Using Digital Technology Application: a Randomized Controlled Trial

Run by Affiliated Hospital of Nantong University · NCT07825311 · Data updated 2026-11-12

This study tests whether a digital prevention program using a wearable and a mobile app can help people who recently had an ischemic stroke reduce the chance of another stroke and improve risk-factor control.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment1696 (estimated)
SponsorAffiliated Hospital of Nantong University
Academic / other
Locations1 site (Nantong, Jiangsu)
StatusRecruiting
StartedSeptember 1, 2026
Main results expectedSeptember 1, 2028
Study endsJune 30, 2029
Registry record updatedNovember 10, 2026
Trial IDNCT07825311 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older who recently had an ischemic stroke (within 3 months) and have both hypertension and diabetes, and can use a smart wearable and smartphone with support.

Probably not a fit

Patients without access to a compatible device or adequate support, or those with conditions limiting participation or follow-up, may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study examines whether a digital prevention program, combining a smart wearable and a mobile application, improves secondary stroke prevention. Participants with a recent ischemic stroke and both hypertension and diabetes are randomly assigned to receive either the digital program plus usual care or usual care alone. Outcomes include stroke recurrence within one year and control of blood pressure, blood glucose, lipids, medication adherence, and lifestyle factors. The study is conducted at the Affiliated Hospital of Nantong University in Nantong, Jiangsu, and uses a wearable-enabled approach to support monitoring and engagement. Enrollment requires capability to use a wearable and smartphone, with follow-up visits per protocol.

Why it matters

Potential benefit: If successful, the program could reduce stroke recurrence and improve risk-factor management for patients after ischemic stroke.

How similar studies have gone: Previous digital health approaches for secondary stroke prevention have shown promise, but results vary by population and implementation.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 years or older.
* Diagnosed with ischemic stroke within the past 3 months, confirmed by cranial CT or MRI.
* Have both hypertension and diabetes as concurrent metabolic risk factors for stroke recurrence.
* Possess basic communication skills and ability to understand the study content and provide written informed consent.
* The participant or their primary caregiver is able to use a smart wearable device, has access to a smartphone, and is willing to complete follow-up visits as required by the study protocol.

Exclusion Criteria:

* Life expectancy less than 12 months, or presence of severe cardiac, hepatic, renal, or other systemic diseases that would make participation in follow-up inappropriate.
* Severe cognitive impairment, aphasia, psychiatric disorders, or disturbance of consciousness that prevents cooperation with the study, without a stable caregiver to assist.
* Severe physical disability or other reasons that preclude wearing or using the wearable device.
* Currently participating in another interventional study that may affect stroke recurrence outcomes.

Where it's running

  • Affiliated Hospital of Nantong University
    Nantong, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.